Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders.
OBJECTIVE
Prevalence of ADHD in adults is around 2% to 4%. Comorbidity is frequent in ADHD; 75% of patients develop a comorbid disorder across life span, substance use disorder (SUD) being one of the most prevalent.


METHODS
A case-control study was performed to check the criteria and concurrent validity of psychiatric research interview for substance and mental disorders (PRISM) adult ADHD section. Validation was done comparing PRISM with the Conners' Adult ADHD Diagnostic Interview for Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). A convenient sample (N = 80) participated, 40 had diagnosis of SUD and ADHD and 40 had diagnosis of SUD without ADHD. The statistics hypothesis was bivariant, and the confidence level was 95%.


RESULTS
Kappa index concordance was .78, sensitivity of PRISM adult ADHD module was 90%, specificity was 87.5%, positive predictive value was 87.8%, and the negative predictive value was 89.7%.


CONCLUSIONS
PRISM has good psychometric properties to detect ADHD associated with SUD.
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain jaramos@vhebron.net.
Josep Antoni
JA
Ramos-Quiroga
Institut de Neuropsiquiatria i Addiccions, Centre Fòrum, Barcelona, Spain IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
Laura
L
Díaz-Digon
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Marina
M
Comín
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain.
Rosa
R
Bosch
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Gloria
G
Palomar
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain.
J Pablo
JP
Chalita
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain.
Carlos
C
Roncero
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain.
Mariana
M
Nogueira
Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Barcelona, Spain.
Marta
M
Torrens
Servei de Psiquiatria. Hospital Universitari Vall d'Hebron, Barcelona, Spain Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain Departament de Psiquiatria i Medicina Legal. Universitat Autònoma de Barcelona, Spain.
Miguel
M
Casas
D000293:Adolescent; D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000453:epidemiology / Q000523:psychology; D016022:Case-Control Studies; D015897:Comorbidity; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000453:epidemiology* / Q000523:psychology; D008875:Middle Aged; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D011594:Psychometrics / Q000706:statistics & numerical data*; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology; D055815:Young Adult